_________
false
כיטוב פארמה בע"מ
2
381
KITOV PHARMA LTD
Corporation no:
520031238
12724
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
15/07/2020
www.isa.gov.il
www.tase.co.il
Reference:
2020-02-068047
Time of broadcast:
08:17
08:05:02
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM D Notice of Exempt Offering of Securities KITOV PHARMA LTD. החברה מתכבדת להודיע כי פירסמה טופס "די" בקשר למניות של החברה אשר הוצעו לבנק השקעות של החברה אשר נמצא בארה"ב . דוח זה אינו מהווה הצעה או שידול להציע הצעות לרכישת ניירות הערך או למכירת ניירות הערך של החברה, ולא יכולה להיות כל מכירת ניירות הערך בכל מדינה או תחום שיפוט, בו כל הצעה, שידול או מכירה הינה עלולה להיות בלתי חוקית לפני הרישום או קבלת האישורים בהתאם לדיני ניירות ערך בכל מדינה או תחום שיפוט
ea124141-d_kitovpharmaltdEDGAR1_isa.pdf
The submission by the Company to the Israel Securities Authority and the Tel Aviv Stock Exchange of a copy of a Form D originally submitted by the Company to the United States Securities Exchange Commission for the purposes of notifying the United States Securities Exchange Commission, as well for purposes of notifying the applicable State(s) of solicitation, of an exempt offering of securities in the United States of America and within such applicable State(s) of solicitation, should not be deemed an admission by the Company that such submission is required of the Company under the Securities Law 5728-1968 and the Securities Regulations (Periodic and Immediate Reports of Foreign Corporation) 5761-2000, nor an admission by the Company that this submission is necessarily being delivered pursuant to the aforesaid laws and regulations. מניות בהקצאה פרטית לבנק השקעות צרדן.טופס D-
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
23/06/2020
Address:
Menachem Begin St, Azrieli Towers Round Tower
132
,
Tel Aviv
6701101
,
Israel
Tel:
03-9333121
,
Fax:
03-5097196
E-mail address:
info@kitovpharma.com
Company site:
www.kitovpharma.com
Previous names of reporting entity:
KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory:
Masas Ludmer Adi
Position of Signatory in the reporting corporation:
Company Controller
Name of Employer Company:
Address:
Menachem Begin Drive
132
,
Tel Aviv
6701101
Telephone:
03-9333121
Facsimile:
03-5097196
E-mail:
adim@kitovpharma.com
1
Israel